Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeglinski

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
ESMO Open|September 24, 2025
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter studyP Schöffski, A Gazzah, J Trigo, et al.
American Journal of Hematology|September 24, 2017
Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemiaAli T Taher, Antoine N Saliba, Kevin H Kuo, et al.
Proceedings. Biological Sciences|July 28, 2017
Effects of age and reproductive status on individual foraging site fidelity in a long-lived marine predatorStephen C Votier, Annette L Fayet, Stuart Bearhop, et al.
The New England Journal of Medicine|August 12, 2011
Two randomized trials of linaclotide for chronic constipationAnthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
ESMO Open|September 24, 2025
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter studyP Schöffski, A Gazzah, J Trigo, et al.
American Journal of Hematology|September 24, 2017
Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemiaAli T Taher, Antoine N Saliba, Kevin H Kuo, et al.
Proceedings. Biological Sciences|July 28, 2017
Effects of age and reproductive status on individual foraging site fidelity in a long-lived marine predatorStephen C Votier, Annette L Fayet, Stuart Bearhop, et al.
The New England Journal of Medicine|August 12, 2011
Two randomized trials of linaclotide for chronic constipationAnthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Pageof 3